Área restringida

La información contenida en esta página está destinada a veterinarios y/o profesionales de salud animal con capacidad de prescripción y/o dispensación de medicamentos.

– Confirmo que soy veterinario o profesional de salud animal.

– Entiendo que la información disponible en esta página se refiere exclusivamente a productos y autorizaciones en España. La información en otros países, debo consultarla a través de los medios oficiales disponibles en el destino específico o con el Departamento de Exportación.

Vaccine

Print Friendly, PDF & Email

Syva-Bax

Inactivated vaccine against pasteurella infections, suspension for injection

1. Warning

The information available on this page complies with the legislation and texts in vigour in Spain. For all other countries, please refer to the specific local information or contact our Export Department for more information.

*The content of this page is purely informative. For a correct use of the products, please refer to the indications in the Summary of product characteristics..

Quick product information

Active ingredient(s)Route of administrationWaiting timePackaging

Clostridium perfringens type A α toxoid
Clostridium perfringenstype B and C β toxoid
Clostridium perfringenstype B and D ε toxoid
Clostridium Septicum α toxoid
Clostridium novyi type B α toxoid
Clostridium tetani toxoid
Clostridium sordelliitoxoid
Clostridium Chauvoei anaculture

Cattle: Subcutaneous administration
Pigs: intramuscular administration
Goats and sheep: subcutaneous administration

Zero days

50 ml

100 ml

250 ml

Country Availability

Algeria, Azerbaijan, Bulgaria, Cyprus, Georgia, Iran, Iraq, Jordan, Kuwait, Lebanon, Macedonia, Mexico, Morocco, Saudi Arabia, Spain, Syria, Turkey.

If your country is not listed, please contact our export team.

Contactar

Active ingredient(s)

Cl. perfringens type A α toxoid……………………………………….≥ 0.3 IU α*

Cl. perfringens type B and C β toxoid …………………………………≥ 10 IU β*

Toxoide ε de type B and D ε toxoid …………………………………≥ 5 IU ε*

Cl. septicum α toxoid ……………………………………… ≥ 2,5 UI α*

Cl. novyi type B α toxoid ……………………. ≥ 3.5 IU α*

Toxoide de ………………………………………. ≥ 2.5 IU *

Cl. sordellii toxoid ……………………………………………………… 100% protection (in guinea pigs)**

Cl. chauvoei anaculture ……………………………………………………… 100% protection (in guinea pigs)**

* Sufficient quantity for obtaining levels of neutralising antibodies per ml of rabbit serum as indicated in Eur. Ph.

** Level of protection in guinea pigs.

Indications

For the active immunisation of sheep and goats against gangrenous mastitis caused by Staphylococcus aureus.
· Enterotoxemia and enterotoxemic jaundice in lambs caused by Clostridium perfringens type A α toxin.
· Enterotoxemia, haemorrhagic gastroenteritis and dysentery caused by Clostridium perfringens type B and C β toxin.
· Enterotoxemia or pulpy kidney disease caused by Clostridium perfringens type B and D ε toxin.
Malignant oedema and carbuncular fever produced by the Clostridium septicum toxin.
Infectious necrotic hepatitis caused by Clostridium novyi type B toxin.
·Tetanus caused by the Clostridium tetanitoxin.
· Enterotoxemia caused by theClostridium sordellii toxin.
· Symptomatic anthrax caused by Clostridium chauvoei

For passive immunisation against the previously mentioned illnesses in newborn animals (target species) born to vaccinated mothers.

In vaccinated animals (any species): immunity against enterotoxemia caused by the Clostridium sordelliitoxin and symptomatic anthrax caused by Clostridium chauvoei is acquired two weeks from administering the second dose from the first vaccine schedule, whereas immunity against the rest of the diseases is acquired at three weeks. This active immunity lasts for 6 months.

Newborn pups born to vaccinated mothers acquire passive immunity after adequate intake of colostrum, and this immunity lasts for up to 50 days of life.

Posology

Shake well before use.
Cattle: 5 ml, Subcutaneous administration
Goats and sheep: 2 ml, Subcutaneous administration
Pigs: 2 ml, Intramuscular administration
Vaccination course
CALVES, LAMBS, KIDS AND PIGLETS
First vaccination: Administer two doses, 4 weeks apart.
For the first vaccination, it is recommended to administer two separate doses 4 weeks apart,
after the 2nd week of life, if born to vaccinated mothers, and from the 12th week
if born to vaccinated mothers.
Revaccination: Administer 1 dose every 6 months.
ADULTS (including non-pregnant females)
First vaccination: Administer two doses, 4 weeks apart.
Revaccination: Administer 1 dose every 6 months.
PREGNANT FEMALES
The active immunisation of mothers during pregnancy ensures passive
protection of young animals for the first 3 months of life.
First vaccination: Administer two doses of the vaccine, one at 4 and one at 8 weeks before the due date.
before the due date.
Revaccination: a single one-dose injection should be administered three weeks
before each subsequent birth.

Waiting time

Zero days.

Packaging

100 ml and 250 ml polypropylene containers.

With veterinary prescription.

Registry no.: 2824 ESP